MacroGenics
Patents, Design & Utilities

Last updated:

List of all MacroGenics patents 67 in total

Status Patent
Application
Utility: TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 25 Jun 2020
Grant
Utility: Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof External link
Filling date: 8 Sep 2025 Issue date: 16 Jun 2020
Grant
Utility: Multi-chain polypeptide-containing tri-specific binding molecules External link
Filling date: 8 Sep 2025 Issue date: 12 May 2020
Application
Utility: FcgammaRIIB-Specific Antibodies and Methods of Use Thereof External link
Filling date: 8 Sep 2025 Issue date: 30 Apr 2020
Grant
Utility: Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof External link
Filling date: 8 Sep 2025 Issue date: 28 Apr 2020
Grant
Utility: Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind to multiple cancer antigens External link
Filling date: 8 Sep 2025 Issue date: 28 Apr 2020
Application
Utility: Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life External link
Filling date: 8 Sep 2025 Issue date: 26 Mar 2020
Grant
Utility: PD-1-binding molecules and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 3 Mar 2020
Application
Utility: BISPECIFIC BINDING MOLECULES THAT ARE CAPABLE OF BINDING CD137 AND TUMOR ANTIGENS, AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: Combination Therapy for the Treatment of Cancer External link
Filling date: 8 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: ADAM9-Binding Molecules, and Methods of Use Thereof External link
Filling date: 8 Sep 2025 Issue date: 19 Dec 2019
Grant
Utility: Multivalent molecules comprising DR5-binding domains External link
Filling date: 8 Sep 2025 Issue date: 10 Dec 2019
Grant
Utility: BCR-complex-specific antibodies and methods of using same External link
Filling date: 8 Sep 2025 Issue date: 19 Nov 2019
Application
Utility: Methods for the Use of CD32B x CD79B-Binding Molecules in the Treatment of Inflammatory Diseases and Disorders External link
Filling date: 8 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: Bi-Specific Monovalent Fc Diabodies That Are Capable of Binding CD32B and CD79b and Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 5 Sep 2019
Application
Utility: COMPOUND TARGETING IL-23A AND B-CELL ACTIVATING FACTOR (BAFF) AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 8 Aug 2019
Application
Utility: HER2/neu-Specific Antibodies and Methods of Using Same External link
Filling date: 8 Sep 2025 Issue date: 1 Aug 2019

Showing 50 to 67 of 67 patents.